Item 2.02. Results of Operations and Financial Condition.
On January 9, 2023, CVRx, Inc. (the "Company") issued a press release announcing
certain preliminary financial results for the quarter and fiscal year ended
December 31, 2022 in connection with its participation in the 41st Annual J.P.
Morgan Healthcare Conference on Wednesday, January 11, 2023. A copy of the press
release is attached as Exhibit 99.1 and is incorporated herein by reference.
The information contained in this Item 2.02, including Exhibit 99.1, is being
furnished and shall not be deemed to be "filed" with the Securities and Exchange
Commission for purposes of Section 18 of the Securities Exchange Act of 1934, as
amended (the "Exchange Act"), or otherwise subject to the liabilities of that
section and is not incorporated by reference into any filing under the
Securities Act of 1933, as amended, or the Exchange Act, whether made before or
after the date hereof, except as expressly set forth by specific reference in
such a filing.
Item 9.01. Financial Statements and Exhibits.
(d) Exhibits
Exhibit
No. Description
99.1 Press release of CVRx, Inc., dated January 9, 2023
104 Cover Page Interactive Data File (embedded within the Inline XBRL document)
© Edgar Online, source Glimpses